SCHEMBL5559

SCHEMBL5559

CC(C)(C)c1ccc(N2CCC3(CCC(C(O)(O)C(F)(F)F)CC3)C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.39
HSD11B1 P28845 4/20 0.34
CYP3A4 P08684 6/20 0.34
ITGB3 P05106 2/20 0.34
ITGA2B P08514 2/20 0.34
USP2 O75604 3/20 0.34
CYP11B1 P15538 3/20 0.33
CYP11B2 P19099 3/20 0.33
HIF1A Q16665 3/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2C9 P11712 2/20 0.33
TSHR P16473 2/20 0.33
CYP2D6 P10635 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615 0.77 HSD11B1 (0.42) FFAR4HSD11B1CYP3A4USP2HIF1A
SCHEMBL25675738 0.76 HSD11B1 (0.40) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL1589620 0.75 EBP (0.47)
SCHEMBL25675741 0.73 HSD11B1 (0.40) HSD11B1CYP3A4USP2HIF1ACYP2C19
SCHEMBL5548 0.72 CYP3A4 (0.36) HSD11B1CYP3A4ITGB3ITGA2BUSP2
SCHEMBL5651 0.70 LIPE (0.38) HSD11B1CYP3A4ITGB3ITGA2BUSP2
SCHEMBL5989 0.69 CYP3A4 (0.40) CYP3A4USP2HIF1ACYP2C19CYP2C9
SCHEMBL11947934 0.69 ITGB3 (0.52) CYP3A4ITGB3ITGA2BHIF1ACYP2C19
SCHEMBL24124025 0.68 HSD11B1 (0.41) HSD11B1USP2CYP2C19CYP2C9CYP2D6
SCHEMBL25675687 0.68 USP2 (0.44) HSD11B1CYP3A4USP2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed